Progressive myoclonic epilepsy type 8

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:424027OMIM:616230G40.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Progressive myoclonic epilepsy type 8 (PME8) is a rare inherited brain disorder caused by changes in the CERS1 gene. This gene gives instructions for making an enzyme called ceramide synthase 1, which is important for the health of nerve cells in the brain and spinal cord. When this enzyme does not work properly, certain fatty substances build up in nerve cells, causing them to break down over time. The main features of PME8 include myoclonus (sudden, brief muscle jerks), seizures, and problems with movement and coordination called ataxia. Over time, people with this condition may also develop difficulty with balance, walking, and speech. The disease is 'progressive,' meaning symptoms tend to worsen gradually over the years. There is currently no cure for PME8. Treatment focuses on managing seizures and muscle jerks using anti-seizure medications, along with physical and occupational therapy to help maintain function and quality of life. Because this is an extremely rare condition, care is best managed by specialists experienced in rare epilepsy syndromes. Early diagnosis and a personalized care plan can make a meaningful difference in day-to-day life.

Also known as:

Key symptoms:

Sudden, brief muscle jerks (myoclonus)Seizures of various typesProblems with balance and coordination (ataxia)Difficulty walking steadilySlurred or slow speechTremor (shaking) of the hands or limbsGradual decline in motor skills over timeSensitivity to light or touch that can trigger muscle jerksFatigue and reduced staminaCognitive difficulties in some individuals

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Progressive myoclonic epilepsy type 8.

View clinical trials →

No actively recruiting trials found for Progressive myoclonic epilepsy type 8 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Progressive myoclonic epilepsy type 8 community →

No specialists are currently listed for Progressive myoclonic epilepsy type 8.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Progressive myoclonic epilepsy type 8.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Progressive myoclonic epilepsy type 8Forum →

No community posts yet. Be the first to share your experience with Progressive myoclonic epilepsy type 8.

Start the conversation →

Latest news about Progressive myoclonic epilepsy type 8

No recent news articles for Progressive myoclonic epilepsy type 8.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which anti-seizure medications are safest for my type of epilepsy, and which ones should I avoid?,How quickly do you expect my symptoms to progress, and what signs should I watch for?,Should other family members be tested for the CERS1 gene mutation?,Are there any clinical trials or research studies I might be eligible for?,What therapies (physical, occupational, speech) do you recommend, and how often should I attend?,What should I do if I have a seizure that lasts more than 5 minutes?,Are there any dietary changes or lifestyle modifications that might help manage my symptoms?

Common questions about Progressive myoclonic epilepsy type 8

What is Progressive myoclonic epilepsy type 8?

Progressive myoclonic epilepsy type 8 (PME8) is a rare inherited brain disorder caused by changes in the CERS1 gene. This gene gives instructions for making an enzyme called ceramide synthase 1, which is important for the health of nerve cells in the brain and spinal cord. When this enzyme does not work properly, certain fatty substances build up in nerve cells, causing them to break down over time. The main features of PME8 include myoclonus (sudden, brief muscle jerks), seizures, and problems with movement and coordination called ataxia. Over time, people with this condition may also develo

How is Progressive myoclonic epilepsy type 8 inherited?

Progressive myoclonic epilepsy type 8 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Progressive myoclonic epilepsy type 8 typically begin?

Typical onset of Progressive myoclonic epilepsy type 8 is juvenile. Age of onset can vary across affected individuals.